Universe Pharmaceuticals INC (UPC)
USD 3.16
(-8.41%)
USD 3.16
(-8.41%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.34 Million USD | 51.52% |
| 2022 | 2.2 Million USD | -10.4% |
| 2021 | 2.46 Million USD | 29.18% |
| 2020 | 1.9 Million USD | -27.11% |
| 2019 | 2.61 Million USD | -67.8% |
| 2018 | 8.12 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 3.75 Million USD | 0.0% |
| 2023 FY | 3.34 Million USD | 51.52% |
| 2023 Q4 | 3.34 Million USD | 0.0% |
| 2023 Q2 | 2.86 Million USD | 0.0% |
| 2022 FY | 2.2 Million USD | -10.4% |
| 2022 Q4 | 2.2 Million USD | 0.0% |
| 2022 Q2 | 3.38 Million USD | 0.0% |
| 2021 Q2 | 4.91 Million USD | 0.0% |
| 2021 FY | 2.46 Million USD | 29.18% |
| 2021 Q4 | 2.46 Million USD | 0.0% |
| 2020 FY | 1.9 Million USD | -27.11% |
| 2020 Q4 | 1.9 Million USD | 0.0% |
| 2020 Q2 | 4.98 Million USD | 0.0% |
| 2019 FY | 2.61 Million USD | -67.8% |
| 2019 Q4 | 2.61 Million USD | 0.0% |
| 2018 FY | 8.12 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cosmos Health Inc. | 4.78 Million USD | 30.189% |
| Safety Shot Inc | 1.86 Million USD | -78.818% |
| Bright Green Corporation | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 97.802% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 96.993% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 50.609% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 89.66% |
| Dynavax Technologies Corporation | 53.29 Million USD | 93.726% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 94.905% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 71.295% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 96.796% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 41.702% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 41.702% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -312.873% |
| Journey Medical Corporation | 10.2 Million USD | 67.242% |
| Alpha Teknova, Inc. | 11.59 Million USD | 71.164% |
| Procaps Group, S.A. | 96.83 Million USD | 96.547% |
| Theratechnologies Inc. | 6.06 Million USD | 44.885% |
| Harrow Health, Inc. | 10.86 Million USD | 69.235% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -22.959% |
| Biofrontera Inc. | 10.9 Million USD | 69.35% |
| DURECT Corporation | 2.21 Million USD | -50.665% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 95.681% |
| Cronos Group Inc. | 30.33 Million USD | 88.98% |
| OptiNose, Inc. | 8.05 Million USD | 58.479% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -334326500.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 41.336% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 88.167% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -24.883% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 27.468% |
| Radius Health, Inc. | 278.64 Million USD | 98.8% |
| ProPhase Labs, Inc. | 3.84 Million USD | 12.958% |
| Phibro Animal Health Corporation | 265.91 Million USD | 98.743% |
| Procaps Group S.A. | 96.83 Million USD | 96.547% |
| Alvotech | 74.43 Million USD | 95.508% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.904% |
| Rockwell Medical, Inc. | 5.87 Million USD | 43.055% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 73.535% |
| SIGA Technologies, Inc. | 64.21 Million USD | 94.794% |
| Tilray Brands, Inc. | 252.08 Million USD | 98.674% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 91.637% |
| Shineco, Inc. | 1.58 Million USD | -110.464% |
| PetIQ, Inc. | 159.3 Million USD | 97.901% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 2288.316% |
| Incannex Healthcare Limited | -10.01 Million USD | 133.383% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 91.271% |
| Alimera Sciences, Inc. | 1.87 Million USD | -77.928% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 91.129% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -107.606% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 25.423% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -1214.425% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 67.791% |
| Hempacco Co., Inc. | 2.54 Million USD | -31.489% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 95.508% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 93.005% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 94.779% |
| Currenc Group, Inc. | 732.91 Thousand USD | -356.163% |
| Kamada Ltd. | 87.74 Million USD | 96.19% |
| Indivior PLC | 141.79 Million USD | 97.642% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -593.854% |
| Flora Growth Corp. | 8.5 Million USD | 60.704% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -1214.425% |
| Evolus, Inc. | 10.99 Million USD | 69.601% |
| HUTCHMED (China) Limited | 50.25 Million USD | 93.348% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 96.841% |
| Akanda Corp. | 1.28 Million USD | -159.793% |